Table 2.
Participant characteristics.
| Variables | Participants |
|---|---|
| Baseline characteristics (n = 23) | |
| Age (years) | 61.7 ± 10.6 |
| Men | 16 (69.6) |
| Weight (kg) | 75.0 ± 18.2 |
| Height (cm) | 170.6 ± 8.0 |
| BMI (kg/m2) | 25.6 ± 4.7 |
| ASA classification, II/III | 10 (43.5)/13 (56.5) |
| Smoking status, current/former/never | 4 (17.4)/9 (39.1)/10 (43.5) |
| Drinking status, current/former/occasional/never | 7 (30.4)/5 (21.7)/6 (26.1)/5 (21.7) |
| High blood pressure | 15 (65.2) |
| Cardiac disease | 7 (30.4) |
| Respiratory disease | 6 (26.1) |
| Diabetes mellitus | 3 (13.0) |
| DASI total score | 38.9 ± 16.5 |
| 6MWT (% pred) | 89.5 ± 19.0 |
| FEV1/VC (% pred) | 93.4 ± 12.8 |
| Creatinin (mg/dL) | 0.8 ± 0.2 |
| Albumin (g/L) | 44.3 ± 2.3 |
| Hemoglobin (g/dL) | 12.5 ± 1.3 |
| C-reactive protein (mg/L) | 3.3 ± 2.3 |
| Tumor location, oesophagus/GE junction/gastric | 16 (69.5)/3 (13.0)/4 (17.4) |
| Adenocarcinoma/squamous carcinoma | 15 (71.4)/6 (28.6) |
| Neoadjuvant treatment, CT/CRT | 3 (13.0)/13 (54.2) |
| Postoperative outcomes (n = 21) | |
| AJCC pStage, 0/I/II/III | 2 (9.5)/9 (42.9)/4 (19.0)/6 (28.6) |
| Surgical procedure, three-field esophagectomy/two-field esophagectomy/gastrectomy | 5 (23.8)/12 (57.1)/4 (19.0) |
| Length of hospital stay (days) | 14.7 ± 9.5 |
| Clavien-Dindo complications, 1/2/3/4/5 | 2 (9.5)/8 (38.1)/2 (9.5)/0 (0.0)/2 (9.5) |
| Readmissions, 30 days/90 days | 1 (4.8)/1 (4.8) |
| In-hospital mortality | 2 (9.5) |
Data are mean ± SD and numbers (percentage) as appropriate. % pred—percentage of predicted value; 6MWT—6 min walk test; AJCC—American Joint Committee on Cancer; ASA—American Society of Anesthesiologists; BMI—body mass index; CRT—chemoradiotherapy; CT—chemotherapy; DASI—Duke Activity Status Index; FEV1—forced expiratory volume in one second; GE—gastroesophageal; VC—vital capacity.